Compare Royal Caribbean Cruises Ltd (RCL) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Caribbean Cruises Ltd vs Tempus AI — how do they compare? Royal Caribbean Cruises Ltd trades at $282.41 (market cap $75.51B), while Tempus AI trades at $70.03 (market cap $12.77B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 5.9× Tempus AI's market cap, and Royal Caribbean Cruises Ltd pays a 2.13% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royal Caribbean Cruises Ltd for 85 Days and Tempus AI for 22 Days on average.
| RCL | TEM | |
|---|---|---|
Market Cap | $75.51B | $12.77B |
Volume | 2,408,997 | 8,980,490 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $348.03 | $99.28 |
52-Week Low | $230.30 | $41.55 |
Typical Hold Time | 85 Days | 22 Days |
Enterprise Value | $98.15B | $13.40B |
Dividend Yield | 2.13% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Royal Caribbean (RCL) trades at $281.39, down 2.58% on the day, amid mixed technical signals with bullish moving averages but overbought RSI levels. Fundamentally, the company shows strong recovery with revenue growing from $8.8B in 2022 to $17.9B in 2025 and net income reaching $4.3B. Recent developments include a $3 billion investment in Sandals Resorts and positive analyst sentiment with 51% buy ratings.
The outlook remains positive with analyst consensus target of $346.67 suggesting 23% upside potential. Key opportunities include expanding resort operations and strong booking trends, while risks involve high debt levels, fuel cost volatility, and execution challenges from the Sandals acquisition. The stock presents a growth opportunity with manageable risks for long-term investors.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
